Old Web
English
Sign In
Acemap
>
Paper
>
1280P Sitravatinib + tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
1280P Sitravatinib + tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
2021
Qing Zhou
Xiaoguang Yu
Bo Gao
Zhiyong Ma
Q. Chu
D. Huang
Jiuran Zhao
Daphne Day
A.L. Body
Hongming Pan
Jiuwei Cui
C. Chen
X. Xiang
C. Fei
L. Yang
Y-L. Wu
Keywords:
non-small cell lung cancer (NSCLC)
Oncology
in patient
Internal medicine
Medicine
Sitravatinib
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]